Skip to main content

Table 4 Microorganism-antimicrobial combinations that did not result in agreement with standard methoda

From: Identification by mass spectrometry and automated susceptibility testing from positive bottles: a simple, rapid, and standardized approach to reduce the turnaround time in the management of blood cultures

Microorganism mE ME VME
E. cloacae Tigecycline (n = 1)
E. coli Piperacillin-tazobactam (n = 3); Amoxicillin-clavulanate (n = 3);
Cefepime (n = 2); Piperacillin-tazobactam (n = 1);
Ceftazidime (n = 2); Co-trimoxazole (n = 1)
Amikacin (n = 1)  
E. faecalis Vancomycin (n = 1)
K. pneumoniae Tigecycline (n = 2)
P. mirabilis Cefepime (n = 1)
S. aureus Erythromycin (n = 1); Clindamycin (n = 2);
Tetracycline (n = 1) Daptomycin (n = 1);
Vancomycin (n = 1)
S. capitis Erythromycin (n = 1) Clindamycin (n = 1);
Teicoplanin (n = 1);
Tetracycline (n = 1);
Vancomycin (n = 1)
S. epidermidis Clindamycin (n = 2); Clindamycin (n = 2); Teicoplanin (n = 2);
Erythromycin (n = 1) Teicoplanin (n = 1) Penicillin (n = 1);
Rifampicin (n = 1)
S. hominis Levofloxacin (n = 1) Clindamycin (n = 1) Clindamycin (n = 1);
Gentamicin (n = 1);
Teicoplanin (n = 1)
S. pneumoniae Erythromycin (n = 2) Erythromycin (n = 1);
Vancomycin (n = 1)
  1. aSome isolates have more than one error. Microorganisms not listed did not have any microorganism-antimicrobial combination errors